mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0006 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0006 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |